These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19656099)

  • 21. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
    Quintana E; Sabate-Rotes A; Maleszewski JJ; Ommen SR; Nishimura RA; Dearani JA; Schaff HV
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):159-67.e1. PubMed ID: 25940414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden cardiac death complicating alcohol septal ablation: a case report and review of literature.
    Antoun P; El Masry H; Breall JA
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):956-9. PubMed ID: 19133681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes.
    Pick JM; Batra AS
    Cardiol Young; 2017 Jan; 27(S1):S126-S131. PubMed ID: 28084973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Card Electrophysiol Clin; 2015 Jun; 7(2):165-71. PubMed ID: 26002383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 33. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
    Cooper RM; Shahzad A; McShane J; Stables RH
    J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes.
    Garratt CJ; Elliott P; Behr E; Camm AJ; Cowan C; Cruickshank S; Grace A; Griffith MJ; Jolly A; Lambiase P; McKeown P; O'Callagan P; Stuart G; Watkins H;
    Europace; 2010 Aug; 12(8):1156-75. PubMed ID: 20663787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertrophic obstructive cardiomyopathy.
    Veselka J; Anavekar NS; Charron P
    Lancet; 2017 Mar; 389(10075):1253-1267. PubMed ID: 27912983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiology patient pages. Hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2002 Nov; 106(19):2419-21. PubMed ID: 12417536
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertrophic cardiomyopathy].
    Batzner A; Seggewiß H
    Herz; 2020 May; 45(3):233-242. PubMed ID: 32185419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.